Toronto therapeutics startup Cyclica Inc using predictive analytics to bring productivity to drug dev process
#HumansofMaRS: Cyclica Inc. taps into predictive analytics to help lower pharma R&D costs - MaRS
It’s no secret that developing a new pharmaceutical drug is expensive work. From research and development to market, the estimated total cost of creating a new drug hovers at around US$2.5 billion on average. As fewer drugs are hitting the market due to rising expenses, Cyclica Inc. believes that big data is the solution to … Read More
Join in on the conversation with Zayna Khayat when you subscribe to Toronto Health.